Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Protagonist Therapeutics (PTGX) Receivables Refunds: 2017-2022

Historic Receivables Refunds for Protagonist Therapeutics (PTGX) over the last 4 years, with Jun 2022 value amounting to $2.6 million.

  • Protagonist Therapeutics' Receivables Refunds fell 4.68% to $2.6 million in Q2 2022 from the same period last year, while for Jun 2022 it was $2.6 million, marking a year-over-year decrease of 4.68%. This contributed to the annual value of $2.8 million for FY2021, which is 157.56% up from last year.
  • Protagonist Therapeutics' Receivables Refunds amounted to $2.6 million in Q2 2022, which was down 7.99% from $2.9 million recorded in Q1 2022.
  • Protagonist Therapeutics' 5-year Receivables Refunds high stood at $2.9 million for Q1 2022, and its period low was $153,000 during Q1 2020.
  • Over the past 3 years, Protagonist Therapeutics' median Receivables Refunds value was $1.8 million (recorded in 2021), while the average stood at $1.7 million.
  • Per our database at Business Quant, Protagonist Therapeutics' Receivables Refunds crashed by 91.84% in 2020 and then soared by 1,091.50% in 2021.
  • Quarterly analysis of 5 years shows Protagonist Therapeutics' Receivables Refunds stood at $1.4 million in 2018, then slumped by 85.02% to $173,000 in 2019, then skyrocketed by 209.25% to $1.1 million in 2020, then spiked by 157.56% to $2.8 million in 2021, then dropped by 4.68% to $2.6 million in 2022.
  • Its last three reported values are $2.6 million in Q2 2022, $2.9 million for Q1 2022, and $2.8 million during Q4 2021.